Coloplast B A/S
Coloplast B A/S
-0,05 %
751,20 DKK
-0,40
Kurs
751,20
Hög
753,40
Förändring
-0,05 %
Låg
744,00
Uppdaterad
2019-06-14
Öppen
750,20
Factsheet for Coloplast B A/S
Company Profile
Description
Coloplast A/S is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 66% of sales from Europe, 20% from North and South America, and 14% from the rest of the world.
Key Stats
Website: http://www.coloplast.com
Headquarter country: Denmark
Employees: 8 000
Market Cap (at close 14-06-2019): DKK 159B
Fiscal Year Ends: september
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 33,40 27,60 32,20 132,60 46,30
Forward Price/Earnings 29,20 26,10 25,40 32,10 32,40
Price/Free Cash Flow 34,80 40,90 42,50 43,80 42,30
Return on Assets 32,30 32,90 28,80 8,50 24,20
Return on Equity 62,20 68,90 64,30 16,40 36,60
Return on Invested Capital 50,70 59,30 62,00 16,00 35,60
Dividend


Dividend/Share:15,50
Ex. Dividend Date:2018-09-30
Trailing Dividend Yield:2,13
Payout Ratio:85,11
Date Currency Amount
2018-12-31 DKK 11,00
2018-06-30 DKK 5,00
2017-12-31 DKK 10,50
2017-06-30 DKK 4,50
2016-12-31 DKK 9,00
2016-06-30 DKK 4,50
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 16 449,00 15 528,00 14 681,00 13 909,00 12 428,00
Gross Profit 11,07 10,57 10,03 9,53 8,54
Gross Margin % 67,27% 68,08% 68,33% 68,54% 68,70%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 5 646,00 5 573,00 4 619,00 1 735,00 3 620,00
Net income 3 845,00 3 797,00 3 143,00 899,00 2 390,00
Basic Earnings Per Share 18,12 17,91 14,80 4,30 11,30
Operating Income 5,09 5,02 4,85 4,54 4,15
Operating Margin % 30,95% 32,35% 33,01% 32,60% 33,37%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 4 361,00 3 251,00 3 028,00 3 337,00 3 149,00
Capital Expenditures -669,00 -685,00 -649,00 -617,00 -533,00
Free Cash Flow 3 692,00 2 566,00 2 379,00 2 720,00 2 616,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets
Long Term Assets
Total Assets
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities
Long Term Liabilities
Total Liabilities
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings
Treasury Stock
Total Stockholder Equity
Net Tangible Assets